Unraveling Immunological Dynamics: HPV Infection in Women-Insights from Pregnancy

Overview

Journal Viruses

Publisher MDPI

Specialty Microbiology

Date 2023 Oct 28

PMID 37896788

Authors

Carmen Elena Condrat

Dragos Cretoiu

Viorica Elena Radoi

Dana Mihaela Mihele

Mihaela Tovaru

Cristian Ioan Bordea

Silviu Cristian Voinea

Nicolae Suciu

Affiliations

Soon will be listed here.

Abstract

During pregnancy, hormonal and immune adaptations are vital for supporting the genetically distinct fetus during elevated infection risks. The global prevalence of HPV necessitates its consideration during pregnancy. Despite a seemingly mild immune response, historical gestational viral infections underscore its significance. Acknowledging the established HPV infection risks during pregnancy, our review explores the unfolding immunological changes in pregnant women with HPV. Our analysis aims to uncover strategies for safely modulating the immune system, mitigating adverse pregnancy consequences, and enhancing maternal and child health. This comprehensive narrative review delves into the existing knowledge and studies on this topic.

Citing Articles

An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis.

Mohammed M, Al-Khafaji Z, Al-Hilli N Tzu Chi Med J. 2025; 37(1):28-41.

PMID: 39850385 PMC: 11753526. DOI: 10.4103/tcmj.tcmj_134_24.

Human Papillomavirus Carcinogenicity and the Need of New Perspectives: Thoughts from a Retrospective Analysis on Human Papillomavirus Outcomes Conducted at the Hospital University of Bari, Apulia, Italy, between 2011 and 2022.

Del Prete R, Nesta D, Triggiano F, Lorusso M, Garzone S, Vitulano L Diagnostics (Basel). 2024; 14(9).

PMID: 38732382 PMC: 11083870. DOI: 10.3390/diagnostics14090968.

References

Tekalegn Y, Sahiledengle B, Woldeyohannes D, Atlaw D, Degno S, Desta F . High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies. Womens Health (Lond). 2022; 18:17455065221075904. PMC: 8819811. DOI: 10.1177/17455065221075904. View

He Y, Wu Y, Wang T, Song F, Wang Y, Zhu L . Perinatal outcomes of pregnant women with cervical intraepithelial neoplasia. Arch Gynecol Obstet. 2013; 288(6):1237-42. DOI: 10.1007/s00404-013-2889-6. View

Luo D, Peng M, Wei X, Pan D, Xue H, Xu Y . Prevalence of Human Papillomavirus and Genotype Distribution in Pregnant and Non-Pregnant Women in China. Risk Manag Healthc Policy. 2021; 14:3147-3157. PMC: 8326939. DOI: 10.2147/RMHP.S288838. View

Delorme-Axford E, Klionsky D . Inflammatory-dependent Sting activation induces antiviral autophagy to limit zika virus in the Drosophila brain. Autophagy. 2018; 15(1):1-3. PMC: 6287683. DOI: 10.1080/15548627.2018.1539585. View

Kreimer A, Sampson J, Porras C, Schiller J, Kemp T, Herrero R . Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial. J Natl Cancer Inst. 2020; 112(10):1038-1046. PMC: 7566548. DOI: 10.1093/jnci/djaa011. View

Lucs A, DeVoti J, Hatam L, Afzal A, Abramson A, Steinberg B . Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11. J Clin Med. 2015; 4(3):375-88. PMC: 4444053. DOI: 10.3390/jcm4030375. View

Tseng C, Liang C, Soong Y, PAO C . Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol. 1998; 91(1):92-6. DOI: 10.1016/s0029-7844(97)00593-0. View

Dorfer S, Strasser K, Reipert S, Fischer M, Shafti-Keramat S, Bonelli M . Deficiency of Cathelicidin-related Antimicrobial Peptide Promotes Skin Papillomatosis in Mus musculus Papillomavirus 1-infected Mice. Acta Derm Venereol. 2020; 101(1):adv00367. PMC: 9309842. DOI: 10.2340/00015555-3733. View

Spoden G, Freitag K, Husmann M, Boller K, Sapp M, Lambert C . Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs). PLoS One. 2008; 3(10):e3313. PMC: 2561052. DOI: 10.1371/journal.pone.0003313. View

10.

Vaernesbranden M, Wiik J, Sjoborg K, Staff A, Carlsen K, Haugen G . Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother-child cohort study. Int J Infect Dis. 2021; 108:574-581. DOI: 10.1016/j.ijid.2021.05.064. View

11.

Srinivas S, Ma Y, Sammel M, Chou D, McGrath C, Parry S . Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006; 195(3):797-802. DOI: 10.1016/j.ajog.2006.05.049. View

12.

Kindt N, Descamps G, Lechien J, Remmelink M, Colet J, Wattiez R . Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. J Clin Med. 2019; 8(1). PMC: 6352225. DOI: 10.3390/jcm8010075. View

13.

Sanchez-Luquez K, Schadock I, Goncalves C, Tornatore M, Finger-Jardim F, Avila E . Impact of TLR7 and TLR9 polymorphisms on susceptibility to placental infections and pregnancy complications. J Reprod Immunol. 2021; 146:103342. DOI: 10.1016/j.jri.2021.103342. View

14.

Moscicki A, Palefsky J . Human papillomavirus in men: an update. J Low Genit Tract Dis. 2011; 15(3):231-4. PMC: 3304470. DOI: 10.1097/LGT.0b013e318203ae61. View

15.

Schabath M, Thompson Z, Egan K, Torres B, Nguyen A, Papenfuss M . Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in Men (HIM) study. Sex Transm Infect. 2014; 91(1):61-7. PMC: 4342055. DOI: 10.1136/sextrans-2013-051422. View

16.

Abrahams V, Schaefer T, Fahey J, Visintin I, Wright J, Aldo P . Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I : C). Hum Reprod. 2006; 21(9):2432-9. DOI: 10.1093/humrep/del178. View

17.

Tartaglia E, Bordoni V, Oliva A, Vergori A, Girardi E, Antinori A . T helper profile in pregnant women recovered from COVID-19. J Reprod Immunol. 2022; 153:103661. PMC: 9258427. DOI: 10.1016/j.jri.2022.103661. View

18.

Yazdani R, Shams-Bakhsh M, Hassani-Mehraban A, Arab S, Thelen N, Thiry M . Production and characterization of virus-like particles of grapevine fanleaf virus presenting L2 epitope of human papillomavirus minor capsid protein. BMC Biotechnol. 2019; 19(1):81. PMC: 6868843. DOI: 10.1186/s12896-019-0566-y. View

19.

Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith J . Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002; 359(9312):1093-101. DOI: 10.1016/S0140-6736(02)08151-5. View

20.

Stelzle D, Tanaka L, Lee K, Ibrahim Khalil A, Baussano I, Shah A . Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020; 9(2):e161-e169. PMC: 7815633. DOI: 10.1016/S2214-109X(20)30459-9. View